McKesson Canada Corporation
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Advocacy regarding retail pharmacy scope of practice and reimbursement issues
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Health
|
|
Advocacy relating to leveraging McKesson's pharmaceutical distribution resources to improve influenza vaccine distribution in BC
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Government Procurement, Health
|
|
Advocating for greater utilization of INVIVA infusion clinics to alleviate infrastructure constraints within BC hospitals
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health, Privatization and Outsourcing
|
|
Policy recommendations regarding PharmaCare reimbursement issues that impact retail pharmacy and pharmaceutical distribution
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|